Capsid virus-like particle display improves recombinant influenza neuraminidase antigen stability and immunogenicity in mice

Research output: Contribution to journalJournal articleResearchpeer-review

Documents

  • Fulltext

    Final published version, 4.64 MB, PDF document

Supplementing influenza vaccines with additional protective antigens such as neuraminidase (NA) is a promising strategy for increasing the breadth of the immune response. Here, we improved the immunogenicity and stability of secreted recombinant NA (rNA) tetramers by covalently conjugating them onto the surface of AP205 capsid virus-like particles (cVLPs) using a Tag/Catcher ligation system. cVLP display increased the induction of IgG2a subclass anti-NA antibodies, which exhibited cross-reactivity with an antigenically distant homologous NA. It also reduced the single dose rNA amounts needed for protection against viral challenge in mice, demonstrating a dose-sparing effect. Moreover, effective cVLP-display was achieved across different NA subtypes, even when the conjugation was performed shortly before administration. Notably, the rNA-cVLP immunogenicity was retained upon mixing or co-administering with commercial vaccines. These results highlight the potential of this approach for bolstering the protective immune responses elicited by influenza vaccines.

Original languageEnglish
Article number110038
JournaliScience
Volume27
Issue number6
Number of pages17
ISSN2589-0042
DOIs
Publication statusPublished - 2024

Bibliographical note

Publisher Copyright:
© 2024

    Research areas

  • Biological sciences, Immune response, Immunology, Natural sciences

ID: 394715196